What is the address of NITIMED?

The registered office of NITIMED is located at Rue de la Closière 5, 1380 Lasne.

Is NITIMED still active?

Yes. According to the CBE (31 October 2026) NITIMED is active, legal situation “Normale toestand”, started on 16 October 1995.

Is NITIMED registered on Peppol?

Yes, NITIMED is registered on the Peppol network with ID 0208:0456183179.

What is the enterprise number of NITIMED?

The enterprise number of NITIMED is BE0456183179.

When was NITIMED founded?

NITIMED was founded on 16 October 1995.

Who are the directors of NITIMED?

According to the 2025 annual accounts, the directors of NITIMED are: Sophie Cran.

Is NITIMED a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 16 October 1995; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did NITIMED make in 2025?

NITIMED posted a profit after taxes of € 51,836 in financial year 2025.

What is the revenue of NITIMED?

As a small company, NITIMED is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 72,369.

NITIMED (Private Limited) - Lasne - BE0456183179

Dossier NITIMED, printed on 31 October 2026 from databakkes.be/en/0456183179/nitimed. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

NITIMED from Lasne, company number BE0456183179, closed financial year 2025 with a result of € 51,836 after tax. For that financial year NITIMED recorded a gross margin of € 72,369 and equity of € 758,398. Compared with financial year 2024, the result moved from € 141,501 to € 51,836. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 5, 2026.

What it is worth Growing

€ 758,398

▲ 2% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 51,836

▼ 63% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 738,523

▲ 3% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 38,400 paid out

74 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 9,224

▲ € 8,775 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,433

▼ 25% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 5,180

▼ 75% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 231,483 Gross margin 2022: € 231,483 First fiscal year in the series	€ 218,044 Gross margin 2023: € 218,044 ▼ 6% vs 2022 (€ 231,483) Unfavourable step	€ 192,276 Gross margin 2024: € 192,276 ▼ 12% vs 2023 (€ 218,044) Unfavourable step	€ 72,369 Gross margin 2025: € 72,369 ▼ 62% vs 2024 (€ 192,276) Unfavourable step	▼ 62%
Profit after taxes	€ 153,607 Profit after taxes 2022: € 153,607 First fiscal year in the series	€ 135,174 Profit after taxes 2023: € 135,174 ▼ 12% vs 2022 (€ 153,607) Unfavourable step	€ 141,501 Profit after taxes 2024: € 141,501 ▲ 5% vs 2023 (€ 135,174) Favourable step	€ 51,836 Profit after taxes 2025: € 51,836 ▼ 63% vs 2024 (€ 141,501) Unfavourable step	▼ 63%
Equity	€ 484,788 Equity 2022: € 484,788 First fiscal year in the series	€ 603,462 Equity 2023: € 603,462 ▲ 24% vs 2022 (€ 484,788) Favourable step	€ 744,963 Equity 2024: € 744,963 ▲ 23% vs 2023 (€ 603,462) Favourable step	€ 758,398 Equity 2025: € 758,398 ▲ 2% vs 2024 (€ 744,963) Favourable step	▲ 2%
Total debts	€ 71,109 Total debts 2022: € 71,109 First fiscal year in the series	€ 49,150 Total debts 2023: € 49,150 ▼ 31% vs 2022 (€ 71,109) Favourable step	€ 29,110 Total debts 2024: € 29,110 ▼ 41% vs 2023 (€ 49,150) Favourable step	€ 6,613 Total debts 2025: € 6,613 ▼ 77% vs 2024 (€ 29,110) Favourable step	▼ 77%
Cash	€ 501,200 Cash 2022: € 501,200 First fiscal year in the series	€ 8,476 Cash 2023: € 8,476 ▼ 98% vs 2022 (€ 501,200) Unfavourable step	€ 714,070 Cash 2024: € 714,070 ▲ € 705,594 vs 2023 (€ 8,476) Favourable step	€ 738,523 Cash 2025: € 738,523 ▲ 3% vs 2024 (€ 714,070) Favourable step	▲ 3%
Retained profit	€ 478,591 Retained profit 2022: € 478,591 First fiscal year in the series	€ 597,265 Retained profit 2023: € 597,265 ▲ 25% vs 2022 (€ 478,591) Favourable step	€ 738,765 Retained profit 2024: € 738,765 ▲ 24% vs 2023 (€ 597,265) Favourable step	€ 752,201 Retained profit 2025: € 752,201 ▲ 2% vs 2024 (€ 738,765) Favourable step	▲ 2%
Dividend	€ 67,439 Dividend 2022: € 67,439 First fiscal year in the series	€ 16,500 Dividend 2023: € 16,500 ▼ 76% vs 2022 (€ 67,439) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 16,500) Unchanged	€ 38,400 Dividend 2025: € 38,400 Unchanged (€ 0) Unchanged
Bank debt	€ 1,250 Bank debt 2022: € 1,250 First fiscal year in the series	€ 1,250 Bank debt 2023: € 1,250 Unchanged (€ 1,250) Unchanged	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 1,250) Favourable step	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 555,897 Balance sheet total 2022: € 555,897 First fiscal year in the series	€ 652,612 Balance sheet total 2023: € 652,612 ▲ 17% vs 2022 (€ 555,897) Unchanged	€ 774,073 Balance sheet total 2024: € 774,073 ▲ 19% vs 2023 (€ 652,612) Unchanged	€ 765,011 Balance sheet total 2025: € 765,011 ▼ 1% vs 2024 (€ 774,073) Unchanged	▼ 1%

Key figures of NITIMED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 June 2027.

What happened to NITIMED?

What happened at NITIMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 5, 2026 New annual accounts for financial year 2025: profit of € 51,836 (▼ 63% vs 2024). filed late Source: NBB ↗
Oct 16, 1995 Start of the company according to the CBE. KBO

In short

From € 153,607 profit in 2022 to € 51,836 profit in 2025.

Paid € 229,732 in corporate taxes since 2022.

Best year ever: 2022, with € 153,607 profit.

Paid out € 122,339 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Sophie Cran

NITIMED

Behind NITIMED is Sophie Cran.

Directors

According to the 2025 annual accounts

Sophie Cran

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de la Closière 5

1380 Lasne

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.

All companies at this address →

B&M PROD

€ 35,177 revenue · 2024

Guévar Jean-Louis

Haenecour Caroline

Partnership, Risk & Services

€ 382 gross margin · 2025

Livres pour Noël

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0456.183.179
VAT number: BE 0456.183.179
Registered office: Rue de la Closière 5, 1380 Lasne
Names & denominations: NITIMED
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 16 October 1995
Peppol: Active · Active since 22 Sept 2026
Contact: [email protected]

View on CBE Public ↗ Annual accounts (NBB) ↗